Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
01/2002
01/02/2002EP1165472A1 Methods for the preparation of biphenyl isoxazole sulfonamides
01/02/2002EP1165084A1 Inhibitors of prenyl-protein transferases
01/02/2002EP1165082A1 Inhibitors of prenyl-protein transferase
01/02/2002EP1165013A2 Inhibitors of prenyl-protein transferase
01/02/2002EP1164848A1 Compositions and methods for preventing and treating sexual dysfunctions
01/02/2002CN1329610A Chromenone and chromanone derivatives as integrin inhibitors
01/02/2002CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/02/2002CN1328824A Compound for curing female sexual disorder
01/01/2002US6335463 Copper catalyzed arylation of 2,5-dichlorobenzoic acid with n-(4-fluorophenyl)glycine in which alkali metal salts are employed in aqueous alkaline environment
01/01/2002US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids
01/01/2002US6335451 Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them
01/01/2002US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
01/01/2002US6335440 Method for detecting oligonucleotides using energy transfer dyes with long stoke shift
01/01/2002US6335343 Inhibitors of prenyl-protein transferase
01/01/2002US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis
12/2001
12/27/2001WO2001098276A1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations
12/27/2001WO2001098263A1 Method for producing aliphatic sulphonic acid chlorides from sulphonic acids
12/27/2001WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
12/27/2001WO2001097810A2 Use of therapeutic benzamide derivatives
12/27/2001WO2001028979A3 Inhibitors of neuraminidases
12/27/2001WO2000064864A9 N-protected amines and their use as prodrugs
12/27/2001US20010056123 Benzamidine derivatives
12/27/2001US20010056110 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes
12/27/2001US20010056109 Imidazole derivatives
12/27/2001US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc.
12/27/2001CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
12/26/2001CN1328466A Use of antifungal agents for treating scleroses
12/26/2001CN1327986A Ion type liquid
12/26/2001CA2351215A1 Use of ergothioneine and/or its derivatives as an antiglycation agent
12/25/2001US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/25/2001US6333343 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
12/25/2001US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/20/2001WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists
12/20/2001WO2001096313A1 Distamycin a analogs
12/20/2001WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/20/2001WO2001096305A1 Serine protease inhibitors
12/20/2001WO2001096281A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
12/20/2001WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use
12/20/2001WO2001051456A3 Antibacterial agents
12/20/2001US20010053851 Antidiabetic agents
12/20/2001US20010053823 Polyimidazoles
12/20/2001DE10028950A1 High yield caprolactam production by catalytic hydrogenation of a cyanovaleric acid derivative, followed by catalytic cyclization of the aminocaproic acid derivative-containing mixture obtained
12/19/2001EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
12/19/2001EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001EP0813564B1 Mannich base polymers
12/19/2001CN1327443A Substituted anilides
12/19/2001CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/19/2001CN1326936A Ion liquid
12/18/2001US6331633 Antidiabetic agents with no liver toxicity
12/18/2001US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors
12/18/2001US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001US6331542 Protease inhibitors
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/18/2001CA2006309C Azolylmethylcyclopentane benzylidene fungicide
12/13/2001WO2001094318A2 Method for synthesis of substituted azole libraries
12/13/2001WO2001094317A2 Method for synthesis of substituted azole libraries
12/13/2001WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
12/13/2001WO2001044200A3 Selective neurokinin antagonists
12/13/2001WO2001036660A3 Transition metal complexes attached to a polymer via a flexible chain
12/13/2001US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis
12/13/2001US20010051614 Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
12/13/2001US20010049848 Direct dyes; hair dyes
12/13/2001DE10027995A1 Ionische Flüssigkeiten II Ionic Liquids II
12/13/2001DE10001037C1 Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen Processes and intermediates for the preparation of imidazopyridines
12/12/2001EP1162204A1 Ionic liquids
12/12/2001EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001EP0912499B1 Pesticides
12/12/2001CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts
12/11/2001US6329529 Nitrogen-based halogenating agents and process for preparing halogen-containing compounds
12/11/2001US6329404 Pharmaceutical composition
12/11/2001US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001US6329374 Non-systemic control of parasites
12/11/2001US6329371 α-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
12/11/2001US6329369 Methods of treating pain and other conditions
12/11/2001US6329360 Hetero-linked phenylglycinolamides
12/11/2001US6329194 Quantitative analysis
12/11/2001US6329154 Histamine measuring apparatus and a histamine measuring method
12/06/2001WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001WO2001092215A2 Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
12/06/2001WO2001091807A2 Ethylenedicysteine (ec)-drug conjugates
12/06/2001WO2001091752A1 Melanocortin receptor agonists
12/06/2001US20010049446 C-C9-Heteroaryl, linked via C or N, substituted or unsubstitued by 1,3-substituents, substituted benzoylguanidine derivatives useful for treating ischemia, cardiac infarct, angina pectoris, and storke etc.
12/06/2001US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/06/2001DE10026565A1 Ionische Flüssigkeiten Ionic Liquids
12/06/2001CA2736344A1 Tnf-.alpha. production inhibitors
12/06/2001CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/06/2001CA2410597A1 Melanocortin receptor agonists
12/05/2001EP1160249A2 Ionic liquids
12/05/2001EP1160240A1 Guanylhydrazones for treating inflammatory conditions
12/05/2001EP1159275A2 Imidazole compounds as histamine h3 ligands
12/05/2001EP1159264A2 INHIBITORS OF FACTOR Xa
12/05/2001EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001EP1159261A2 Antizyme modulators and their use
12/05/2001EP1158983A1 Inhibitors of prenyl-protein transferase
12/05/2001EP1158982A2 Inhibitors of prenyl-protein transferase
12/05/2001EP0991793B1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
12/05/2001EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001CN1325385A Gastrin and cholecystokinin receptor ligands